Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	指定難病告示番号
1	2011-2012 seasonal flu vaccine intramuscular	-	-	-	-	2件:  3 , 113 💬
2	2011-2012 seasonal flu vaccine subcutaneous	-	-	-	-	2件:  3 , 113 💬
3	4-aminopyridine	Dalfampridine	1件: D04127 💬	4件: KCNA4, KCNC3, KCND2, KCND3 💬	4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	2件:  3 , 13 💬
4	4-cholesten-3-one, oxime	-	-	-	-	2件:  2 ,  3  💬
5	4-cholesten-3-one,oxime	-	-	-	-	1件:  3  💬
6	Adipose derived mesenchymal stem cell	-	-	-	-	1件:  3  💬
7	Air	-	-	-	-	7件:  3 , 51, 58, 85, 97, 193, 299 💬
8	Amifampridine	Amifampridine	1件: D10228 💬	4件: KCNA4, KCNC3, KCND2, KCND3 💬	4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	3件:  3 , 11, 12 💬
9	Amifampridine phosphate	Amifampridine	1件: D10228 💬	4件: KCNA4, KCNC3, KCND2, KCND3 💬	4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	3件:  3 , 11, 12 💬
10	Amifampridine phosphate 10 mg oral tablet	Amifampridine	1件: D10228 💬	4件: KCNA4, KCNC3, KCND2, KCND3 💬	4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	1件:  3  💬
11	Avxs-101	-	-	-	-	1件:  3  💬
12	Avxs-101 (previously known as scaav9.cb.smn)	-	-	-	-	1件:  3  💬
13	Biocarn	-	-	-	-	1件:  3  💬
14	Branaplam	Branaplam	-	-	-	1件:  3  💬
15	Celecoxib	Celecoxib	1件: D00567 💬	1件: PTGS2 💬	22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
16	Gh	-	-	-	-	1件:  3  💬
17	Human anti-promyostatin monoclonal antibody	-	-	-	-	1件:  3  💬
18	Hydroxyurea	Hydroxyurea	1件: D00341 💬	1件: RRM2 💬	6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway	8件:  3 , 13, 19, 20, 65, 85, 86, 284 💬
19	Isis 396443	-	-	-	-	1件:  3  💬
20	Isis 396443 (biib058)	-	-	-	-	1件:  3  💬
21	Isis 396443, biib058	-	-	-	-	1件:  3  💬
22	Itraconazole	Itraconazole	1件: D00350 💬	-	-	4件:  3 , 65, 227, 299 💬
23	Leuprolide	Leuprolide	2件: D00989, D08113 💬	1件: GNRHR 💬	2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction	5件:  1 ,  2 ,  3 , 51, 76 💬
24	Levocarnitine	Levocarnitine	3件: D02030, D02176, D04713 💬	-	-	3件:  3 , 53, 97 💬
25	Lmi070	-	-	-	-	1件:  3  💬
26	Mestinon	-	-	-	-	3件:  3 ,  6 , 11 💬
27	Midazolam	Midazolam	3件: D00550, D00696, D05028 💬	16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬	7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction	11件:  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 298 💬
28	N.a.	-	-	-	-	10件:  3 ,  6 ,  8 , 13, 46, 96, 97, 240, 256, 271 💬
29	Nerve growth factor	Nerve Growth Factor	-	-	-	2件:  3 , 90 💬
30	Norditropin simplexx	-	-	-	-	4件:  3 , 78, 193, 195 💬
31	Norditropin simplexx 15 mg/1.5 ml	-	-	-	-	1件:  3  💬
32	Nursinersen	-	-	-	-	1件:  3  💬
33	Nusinersen	Nusinersen	1件: D10881 💬	1件: SMN2 💬	1件: RNA transport	1件:  3  💬
34	Nusinersen injectable product	Nusinersen	1件: D10881 💬	1件: SMN2 💬	1件: RNA transport	1件:  3  💬
35	Nusinersen sodium	Nusinersen	1件: D10881 💬	1件: SMN2 💬	1件: RNA transport	1件:  3  💬
36	Nusinersen treatments	Nusinersen	1件: D10881 💬	1件: SMN2 💬	1件: RNA transport	1件:  3  💬
37	Olesoxime	-	-	-	-	2件:  2 ,  3  💬
38	Onasemnogene abeparvovec	Onasemnogene abeparvovec	1件: D11559 💬	1件: SMN1 💬	1件: RNA transport	1件:  3  💬
39	Onasemnogene abeparvovec-xioi	Onasemnogene abeparvovec	1件: D11559 💬	1件: SMN1 💬	1件: RNA transport	1件:  3  💬
40	Orfiril saft	-	-	-	-	1件:  3  💬
41	Other: monthly assessments of functional motor abilities by a trained therapist	-	-	-	-	1件:  3  💬
42	Other: prospective observational registry	-	-	-	-	1件:  3  💬
43	Paracetamol	Acetaminophen	1件: D00217 💬	2件: PTGS1, PTGS2 💬	23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	5件:  3 ,  6 , 13, 35, 46 💬
44	Paracetamol 120mg/5ml oral suspension	Acetaminophen	1件: D00217 💬	2件: PTGS1, PTGS2 💬	23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	1件:  3  💬
45	Phenylbutyrate	Phenylbutyric acid	1件: D05868 💬	-	-	11件:  2 ,  3 ,  6 ,  8 , 15, 93, 94, 244, 251, 297, 299 💬
46	Phosphate	Phosphate ion	-	-	-	30件:  2 ,  3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬
47	Placebo	-	-	-	-	26件:  3 ,  5 ,  6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬
48	Procedure: air stacking manuever	-	-	-	-	1件:  3  💬
49	Procedure: sham procedure	-	-	-	-	1件:  3  💬
50	Pyridostigmine	Pyridostigmine	1件: D00487 💬	1件: ACHE 💬	2件: Cholinergic synapse, Glycerophospholipid metabolism	4件:  3 ,  6 , 11, 256 💬
51	Pyridostigmine bromide	Pyridostigmine	1件: D00487 💬	1件: ACHE 💬	2件: Cholinergic synapse, Glycerophospholipid metabolism	3件:  3 ,  6 , 256 💬
52	Reldesemtiv	Reldesemtiv	1件: D11363 💬	1件: TNNC2 💬	1件: Calcium signaling pathway	2件:  2 ,  3  💬
53	Reldesemtiv 150 mg	Reldesemtiv	1件: D11363 💬	1件: TNNC2 💬	1件: Calcium signaling pathway	1件:  3  💬
54	Reldesemtiv 450 mg	Reldesemtiv	1件: D11363 💬	1件: TNNC2 💬	1件: Calcium signaling pathway	1件:  3  💬
55	Riluzole	Riluzole	1件: D00775 💬	14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬	23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway	8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206 💬
56	Risdiplam	Risdiplam	1件: D11406 💬	1件: SMN2 💬	1件: RNA transport	1件:  3  💬
57	Ro6885247	-	-	-	-	1件:  3  💬
58	Ro6885247/f02	-	-	-	-	1件:  3  💬
59	Ro6885247/f03	-	-	-	-	1件:  3  💬
60	Ro7034067	-	-	-	-	1件:  3  💬
61	Ro7034067 / f12	-	-	-	-	1件:  3  💬
62	Ro7034067 / f13	-	-	-	-	1件:  3  💬
63	Ro7034067/f06 + solvente (ro	-	-	-	-	1件:  3  💬
64	Ro7034067/f06 with solvent (ro7034067/f08)	-	-	-	-	1件:  3  💬
65	Ro7034067/f07 + solvente (ro	-	-	-	-	1件:  3  💬
66	Ro7034067/f07 with solvent (ro7034067/f09)	-	-	-	-	1件:  3  💬
67	Ro7034067/f12	-	-	-	-	1件:  3  💬
68	Ro7034067/f13	-	-	-	-	1件:  3  💬
69	Ro7090919	-	-	-	-	1件:  3  💬
70	Rvg 03820	-	-	-	-	1件:  3  💬
71	Salbutamol	Salbutamol	1件: D02147 💬	1件: ADRB2 💬	8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	9件:  3 , 11, 49, 85, 86, 111, 228, 256, 299 💬
72	Sesame oil	Sesame oil	1件: D03314 💬	-	-	1件:  3  💬
73	Sesame oil, refined	Sesame oil	1件: D03314 💬	-	-	1件:  3  💬
74	Smart	-	-	-	-	1件:  3  💬
75	Sodium phenylbutyrate	Phenylbutyric acid	1件: D05868 💬	-	-	4件:  2 ,  3 ,  8 , 251 💬
76	Sodium phenylbutyrate (napb)	Phenylbutyric acid	1件: D05868 💬	-	-	1件:  3  💬
77	Somatotropin	Somatotropin	1件: D02691 💬	1件: GHR 💬	5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway	3件:  3 , 78, 236 💬
78	Somatropin	Somatotropin	1件: D02691 💬	1件: GHR 💬	5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway	16件:  2 ,  3 , 19, 46, 74, 75, 78, 96, 113, 187, 193, 195, 265, 274, 276, 299 💬
79	Spinraza	-	-	-	-	1件:  3  💬
80	Srk-015	-	-	-	-	1件:  3  💬
81	Survival of motor neuron 2 (smn2) splicing modulator antisense oligonucleotide	-	-	-	-	1件:  3  💬
82	Testosterone	Testosterone	6件: D00075, D00957, D00958, D00959, D06085, D06087 💬	1件: AR 💬	3件: Oocyte meiosis, Pathways in cancer, Prostate cancer	8件:  1 ,  2 ,  3 , 13, 60, 78, 113, 265 💬
83	Tro19622	TRO19622	-	-	-	3件:  2 ,  3 , 13 💬
84	Valproate	Valproic acid	1件: D00399 💬	7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬	17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism	6件:  2 ,  3 , 90, 102, 233, 256 💬
85	Valproate sodium	Valproic acid	1件: D00399 💬	7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬	17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism	1件:  3  💬
86	Valproate, levocarnitine	Levocarnitine	4件: D00399, D02030, D02176, D04713 💬	7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬	17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism	1件:  3  💬
87	Valproic acid	Valproic acid	1件: D00399 💬	7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬	17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism	10件:  3 ,  5 , 26, 34, 65, 89, 90, 222, 256, 331 💬
88	Valproic acid (vpa)	Valproic acid	1件: D00399 💬	7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬	17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism	1件:  3  💬
89	Valproic acid and levocarnitine	Levocarnitine	4件: D00399, D02030, D02176, D04713 💬	7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬	17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism	1件:  3  💬
90	Volmax*30cpr 4mg r.p.	-	-	-	-	1件:  3  💬
91	Vpa	-	-	-	-	1件:  3  💬
92	Zolgensma	-	-	-	-	1件:  3  💬

先頭へ